Skip to main content

Advertisement

Log in

Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Rats that recovered from mild proximal tubule (PT) injury without renal dysfunction by subtoxic insult, developed partial resistance to subsequent nephrotoxic insult. This partial resistance was associated with reduced renal dysfunction and accelerated PT cell proliferation compared with vehicle treatment as the first insult. Here we assessed the role and potential mechanisms of accelerated PT proliferation in this acquired resistance model.

Methods

Rats at 14 days after recovering from prior mild renal damage induced by 0.2 mg/kg uranyl acetate (UA) (subtoxic dose) were rechallenged with 4 mg/kg UA (nephrotoxic dose) to establish the acquired resistance model. Cell cycle was inhibited by colchicine to examine the contribution of accelerated PT cell proliferation evaluated by in vivo bromodeoxyuridine (BrdU) labeling on acquired resistance to subsequent nephrotoxic insult. Hepatocyte growth factor (HGF)/c-Met axis and other related factors of cell cycle were analyzed.

Results

The acquired resistance to rechallenge injury with nephrotoxic dose of UA in rats recovered from mild renal injury was associated with an earlier increase in BrdU-positive PT cells, accelerated upregulation of HGF mRNA, c-Met mRNA/protein, cyclin D1, phospho-Rb and an earlier phenotypic change of PT cells. Colchicine inhibited PT cell proliferation, reduced the upregulated cyclin D1 and phospho-Rb in the kidney, completely abolishing acquired resistance.

Conclusions

Cell cycle progression with upregulated renal HGF/c-Met axis may contribute to the accelerated recovery from acute renal failure in rats that recovered from prior mild renal damage, followed by nephrotoxic insult, resulting in partial acquired resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Honda N, Hishida A, Ikuma K, Yonemura K. Acquired resistance to acute renal failure. Kidney Int. 1987;31:1233–8.

    Article  CAS  PubMed  Google Scholar 

  2. Furuya R, Kumagai H, Hishida A. Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells. J Lab Clin Med. 1997;129:347–55.

    Article  CAS  PubMed  Google Scholar 

  3. Zager RA, Burkhart KM, Johnson AC, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and “acquired cytoresistance”. Kidney Int. 1999;56:1788–97.

    Article  CAS  PubMed  Google Scholar 

  4. Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000;58:193–205.

    Article  CAS  PubMed  Google Scholar 

  5. Kawaida K, Matsumoto K, Shimazu H, Nakamura K. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–54.

    Article  CAS  PubMed  Google Scholar 

  7. Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–57.

    Article  CAS  PubMed  Google Scholar 

  8. Sharples EJ. Acute kidney injury: stimulation of repair. Curr Opin Crit Care. 2007;13:652–5.

    Article  PubMed  Google Scholar 

  9. Mizuno S, Fujita K, Furuya R, Hishid A, Ito H, Tashim Y, et al. Association of HSP73 with the acquired resistance to uranyl acetate-induced acute renal failure. Toxicology. 1997;117:183–91.

    Article  CAS  PubMed  Google Scholar 

  10. Sano K, Fujigaki Y, Miyaji T, Ikegaya N, Ohishi K, Yonemura K, et al. Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate. Kidney Int. 2000;57:1560–70.

    Article  CAS  PubMed  Google Scholar 

  11. Ikuma K, Honda N, Hishida A, Nagase M. Loss of glomerular responses to vasoconstrictor agents in rabbits recovering from ARF. Kidney Int. 1986;30:836–41.

    Article  CAS  PubMed  Google Scholar 

  12. Sun Y, Fujigaki Y, Sakakima M, Hishida A. Acquired resistance to rechallenge injury in rats recovered from subclinical renal damage with uranyl acetate—importance of proliferative activity of tubular cells. Toxicol Appl Pharmacol. 2010;243:104–10.

    Article  CAS  PubMed  Google Scholar 

  13. Mehendale HM, Thakore KN, Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol. 1994;9:131–9.

    Article  CAS  PubMed  Google Scholar 

  14. Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. Role of tissue repair in survival from s-(1, 2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol Sci. 2003;74:215–27.

    Article  CAS  PubMed  Google Scholar 

  15. Korrapati MC, Chilakapati J, Lock EA, Latendresse JR, Warbritton A, Mehendale HM. Preplaced cell division: a critical mechanism of autoprotection against S-1, 2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am J Physiol Renal Physiol. 2006;291:F439–55.

    Article  CAS  PubMed  Google Scholar 

  16. Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, et al. Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant. 2009;24:2686–92.

    Article  CAS  PubMed  Google Scholar 

  17. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.

    Article  CAS  PubMed  Google Scholar 

  18. Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–53.

    Article  CAS  PubMed  Google Scholar 

  19. Rao VC, Mehendale HM. Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol. 1993;67:392–400.

    Article  CAS  PubMed  Google Scholar 

  20. Dalu A, Rao PS, Mehendale HM. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality. Environ Health Perspect. 1998;106:597–606.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23:2198–205.

    Article  CAS  PubMed  Google Scholar 

  22. Qiu J, Liu Z, Da L, Li Y, Xuan H, Lin Q, et al. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4. J Hepatol. 2007;46:266–75.

    Article  CAS  PubMed  Google Scholar 

  23. Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, et al. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med. 2006;17:857–64.

    CAS  PubMed  Google Scholar 

  24. Del Signore A, De Sanctis V, Di Mauro E, Negri R, Perrone-Capano C, Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J Neurosci. 2006;23:65–74.

    Article  PubMed  Google Scholar 

  25. Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, et al. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. 2006;21:41–50.

    Article  CAS  PubMed  Google Scholar 

  26. Li C, Yang CW, Ahn HJ, Kim WY, Park CW, Park JH, et al. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Nephron. 2002;92:422–30.

    Article  CAS  PubMed  Google Scholar 

  27. Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;297:F200–9.

    Article  CAS  PubMed  Google Scholar 

  28. Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258–61.

    Article  CAS  PubMed  Google Scholar 

  29. Seville LL, Shah N, Westwell AD, Chan WC. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets. 2005;5:159–70.

    Article  CAS  PubMed  Google Scholar 

  30. Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol. 2001;280:F562–73.

    Article  CAS  PubMed  Google Scholar 

  31. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93:2175–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol. 2006;290:R861–70.

    Article  CAS  PubMed  Google Scholar 

  33. Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med. 2008;36:S187–92.

    Article  PubMed  Google Scholar 

  34. Imai E, Isaka Y. Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens. 2002;11:49–57.

    Article  PubMed  Google Scholar 

  35. Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol. 2001;12:531–40.

    CAS  PubMed  Google Scholar 

  36. Tajima H, Higuchi O, Mizuno K, Nakamura T. Tissue distribution of hepatocyte growth factor receptor and its exclusive downregulation in a regenerating organ after injury. J Biochem. 1992;111:401–6.

    Article  CAS  PubMed  Google Scholar 

  37. Leshem Y, Halevy O. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent. J Cell Physiol. 2002;191:173–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was presented in part at the 40th annual meeting of the American Society of Nephrology, San Francisco, CA, 2007. This work was supported by a Grant-In-Aid for scientific research (C; No. 19590945) and (C; No. 22590884) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

Conflict of interest

There is no declared conflict of interest in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Fujigaki.

About this article

Cite this article

Sun, Y., Fujigaki, Y., Sakakima, M. et al. Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis. Clin Exp Nephrol 15, 666–675 (2011). https://doi.org/10.1007/s10157-011-0453-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-011-0453-x

Keywords

Navigation